Viewing Study NCT06090318


Ignite Creation Date: 2025-12-25 @ 4:37 AM
Ignite Modification Date: 2026-01-09 @ 8:31 PM
Study NCT ID: NCT06090318
Status: WITHDRAWN
Last Update Posted: 2023-10-19
First Post: 2022-11-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
Sponsor: Rain Oncology Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module